Author:
Advani Ranjana,Lum Bert L.,Fisher George A.,Halsey Joanne,Geary Richard S.,Holmlund Jon T.,Kwoh T. Jesse,Dorr F. Andrew,Sikic Branimir I.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Oncology
Reference16 articles.
1. Basu A: The potential of protein kinase C as a target for anticancer treatment. Pharmacol Ther 59: 257–280, 1993
2. Blobe GC, Obeid LM, Hannun YA: Regulation of protein kinase C and role in cancer biology. Cancer Metastasis Rev 13: 411–431, 1994
3. Henry SP, Montheith D, Bennett F, Levin AA: Toxicological and pharmacokinetic properties of chemically modified antisense oligonucleotide inhibitors of PKC-α and C-raf kinase. Anticancer Drug Des 12: 409–420, 1997
4. Dean NM, McKay R: Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 91: 11762–11766, 1994
5. Yazaki T, Ahmad S, Chahlavi A, Zylber-Katz E, Dean NM, Rabkin SD, Martuza RL, Glazer RI: Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-α phosphorothioate oligodeoxynucleotide. Mol Pharmacol 50: 236–242, 1996
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献